HIV

Antiretroviral Therapy's Positive Impact On Global Public Health Faces Challenges Moving Forward
Antiretroviral Therapy's Positive Impact On Global Public Health Faces Challenges Moving Forward
Forbes
HIV
Public Health
antiretrovirals
Flag link:
Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Medical Devices and Diagnostics Industry
Roche
viral assays
HIV
HPV
diagnostics
Global Access Program
Flag link:
FDA AdCom backs Gilead's move to expand Descovy label — but stops short of endorsing broad PrEP use
FDA AdCom backs Gilead's move to expand Descovy label — but stops short of endorsing broad PrEP use
Endpoints
FDA
Gilead Sciences
HIV
Descovy
PrEP
Flag link:
Regulators, Gilead at odds over HIV drug's use in women
Regulators, Gilead at odds over HIV drug's use in women
Biopharma Dive
Gilead Sciences
HIV
Descovy
Flag link:
ViiV’s first-in-class HIV drug on course for filings this year
ViiV’s first-in-class HIV drug on course for filings this year
Pharmaforum
ViiV Healthcare
HIV
fostemsavir
FDA
Flag link:
Busy Gilead crew throws struggling biotech a lifeline, with some cash upfront and hundreds of millions in biobucks for HIV deal
Busy Gilead crew throws struggling biotech a lifeline, with some cash upfront and hundreds of millions in biobucks for HIV deal
Endpoints
Gilead Sciences
Durect
HIV
hepatitis B
extended release
Flag link:
J&J gears up for clinical test of HIV vaccine efficacy
J&J gears up for clinical test of HIV vaccine efficacy
Fierce Biotech
JNJ
clinical trials
HIV
vaccines
Flag link:
Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY
Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY
Yahoo/Zacks.com
GSK
HIV
FDA
Merck
Keytruda
Sanofi
isatuximab
Roche
JNJ
Flag link:
Scripps Research Snags $129 Million for HIV Vaccine Investigation
Scripps Research Snags $129 Million for HIV Vaccine Investigation
BioSpace
Scripps Research Institute
HIV
vaccines
Flag link:
ViiV's HIV Drug Hits Endpoints in Late-Stage Comparison Trial
ViiV's HIV Drug Hits Endpoints in Late-Stage Comparison Trial
BioSpace
GSK
ViiV Healthcare
Dovato
HIV
Flag link:
Gilead and Lyndra Team Up to Develop Long-Acting HIV Therapies
Gilead and Lyndra Team Up to Develop Long-Acting HIV Therapies
BioSpace
Gilead Sciences
Lyndra Therapeutics
HIV
Flag link:
ViiV Healthcare begins study on implementation of once-monthly injectable HIV treatment
ViiV Healthcare begins study on implementation of once-monthly injectable HIV treatment
Pharmaceutical Business Review
ViiV Healthcare
HIV
cabotegravir
rilpivirine
Flag link:
Using CRISPR to eliminate HIV
Using CRISPR to eliminate HIV
Fierce Biotech
HIV
CRISPR
Flag link:
FDA Eliminates REMS for HIV Drug Truvada and its Generics
FDA Eliminates REMS for HIV Drug Truvada and its Generics
RAPS.org
FDA
Gilead Sciences
Truvada
HIV
REMS
Flag link:
U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached?
U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached?
Fierce Pharma
Gilead Sciences
Truvada
HIV
patents
Flag link:
Influential task force urges payers to cover PrEP for HIV
Influential task force urges payers to cover PrEP for HIV
Healthcare Dive
HIV
PrEP
Gilead Sciences
Truvada
Affordable Care Act
US Preventive Services Task Force
Flag link:
Daily HIV prevention pill urged for healthy people at risk
Daily HIV prevention pill urged for healthy people at risk
Stat
HIV
PrEP
Truvada
Gilead Sciences
Flag link:
J&J passes key milestone in HIV vaccine trial
J&J passes key milestone in HIV vaccine trial
Pharmaforum
JNJ
Janssen
clinical trials
vaccines
HIV
Imbokodo
Flag link:
Medicare decides against tighter management of HIV drugs
Medicare decides against tighter management of HIV drugs
Biopharma Dive
HHS
Medicare
HIV
Medicare Part D
Flag link:
Gilead defends Truvada pricing during House hearing
Gilead defends Truvada pricing during House hearing
BioCentury
Gilead Sciences
Truvada
HIV
drug pricing
US Congress
Flag link:

Pages